| Region | Clinics/Networks | |--------|------------------| | | Umemaro Center (Tokyo, Osaka, Fukuoka) – the original “Umemaro Lab”. | | Europe | EU‑Umemoro Consortium – partner hospitals in Germany, Switzerland, and the UK (e.g., University Hospital Basel). | | North America | Pilot program at Stanford Orthopedic Institute (CA) and Mayo Clinic (MN). | | Australia | Sydney Musculoskeletal Research Centre (SMRC). |
The phrase "Umemaro 3D" likely refers to a hypothetical or emerging 3D-based method, such as 3D modeling for surgical planning or virtual reality (VR) for therapy. "Lecherous," meaning lustful, is an odd descriptor and likely a mistranslation. Assuming the intended term was "comprehensive" (e.g., "ryokai-teki" in Japanese), Dr. Sugimoto’s approach may symbolize a thorough, patient-centered treatment strategy enhanced by 3D tools. This interpretation aligns with modern medical trends leveraging technology for precision and care. Umemaro 3d Dr Sugimoto S Lecherous Treatment Full